Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v3.21.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Cash flows from operating activities    
Net loss $ (2,933,866) $ (3,273,581)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization expense 560,972 565,208
Impairment loss   1,607,797
Deferred income taxes, net 79 (17,852)
Gain (loss) on derivatives (23,560) 12,195
Loss on extinguishment of debt 601,539 10,480
Provision for bad debts and inventory obsolescence 14,118 16,293
Gain on involuntary conversion of assets (7,706) (1,340)
Share-based compensation expense 88,974 81,009
Net foreign currency adjustments (7,238) 3,746
Changes in operating assets and liabilities:    
Accounts receivable, net (979,890) (12,103)
Inventories (26,676) 12,757
Prepaid expenses and other assets (65,876) 79,915
Accounts payable 15,014 11,536
Accrued expenses and other liabilities 142,170 (180,126)
Advance ticket sales 469,595 (834,560)
Net cash used in operating activities (2,152,351) (1,918,626)
Cash flows from investing activities    
Additions to property and equipment, net (539,530) (873,142)
Cash paid on settlement of derivatives (14,465) (31,520)
Other 11,024 3,047
Net cash used in investing activities (542,971) (901,615)
Cash flows from financing activities    
Repayments of long-term debt (889,206) (888,800)
Proceeds from long-term debt 1,345,041 5,225,090
Common share issuance proceeds, net 1,558,396 719,094
Proceeds from employee related plans 3,141 5,557
Net share settlement of restricted share units (16,672) (15,334)
Early redemption premium (611,164) (1,376)
Deferred financing fees (59,880) (117,388)
Net cash provided by financing activities 1,329,656 4,926,843
Effect of exchange rates on cash and cash equivalents   (3,267)
Net increase (decrease) in cash and cash equivalents (1,365,666) 2,103,335
Cash and cash equivalents at beginning of period 3,300,482 252,876
Cash and cash equivalents at end of period $ 1,934,816 $ 2,356,211